Marie‐Claude Beauchamp

1.7k total citations
28 papers, 1.2k citations indexed

About

Marie‐Claude Beauchamp is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Marie‐Claude Beauchamp has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Marie‐Claude Beauchamp's work include Metabolism, Diabetes, and Cancer (6 papers), RNA Research and Splicing (5 papers) and Cancer-related Molecular Pathways (4 papers). Marie‐Claude Beauchamp is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), RNA Research and Splicing (5 papers) and Cancer-related Molecular Pathways (4 papers). Marie‐Claude Beauchamp collaborates with scholars based in Canada, United States and Israel. Marie‐Claude Beauchamp's co-authors include Walter H. Gotlieb, Michaël Pollak, Amber Yasmeen, Geneviève Renier, Jing Gu, Susie Lau, Ilan Bruchim, János G. Filep, Chantal Baron and Christine Zouki and has published in prestigious journals such as Journal of Clinical Investigation, Neuron and PLoS ONE.

In The Last Decade

Marie‐Claude Beauchamp

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie‐Claude Beauchamp Canada 18 779 386 239 229 211 28 1.2k
Seiya Sato Japan 19 447 0.6× 297 0.8× 140 0.6× 121 0.5× 183 0.9× 95 1.2k
Luisa Salvatori Italy 20 477 0.6× 182 0.5× 155 0.6× 198 0.9× 57 0.3× 33 1.1k
Marie‐José Blouin Canada 19 675 0.9× 191 0.5× 143 0.6× 232 1.0× 293 1.4× 29 1.1k
Wenru Tang China 20 468 0.6× 271 0.7× 94 0.4× 239 1.0× 74 0.4× 93 1.2k
Yumi Takiyama Japan 21 584 0.7× 218 0.6× 425 1.8× 251 1.1× 370 1.8× 48 1.4k
Krzysztof Goryca Poland 19 762 1.0× 283 0.7× 57 0.2× 326 1.4× 142 0.7× 69 1.3k
Ayce Yesilaltay United States 18 503 0.6× 168 0.4× 95 0.4× 130 0.6× 409 1.9× 20 1.0k
Hisataka Shikama Japan 16 327 0.4× 121 0.3× 131 0.5× 156 0.7× 146 0.7× 28 807
Jinghuan Lv China 18 409 0.5× 147 0.4× 60 0.3× 144 0.6× 230 1.1× 37 885
Ashwini L. Chand Australia 22 753 1.0× 566 1.5× 80 0.3× 242 1.1× 73 0.3× 41 1.6k

Countries citing papers authored by Marie‐Claude Beauchamp

Since Specialization
Citations

This map shows the geographic impact of Marie‐Claude Beauchamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Claude Beauchamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Claude Beauchamp more than expected).

Fields of papers citing papers by Marie‐Claude Beauchamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Claude Beauchamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Claude Beauchamp. The network helps show where Marie‐Claude Beauchamp may publish in the future.

Co-authorship network of co-authors of Marie‐Claude Beauchamp

This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Claude Beauchamp. A scholar is included among the top collaborators of Marie‐Claude Beauchamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Claude Beauchamp. Marie‐Claude Beauchamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahu, Maitreyi, Azalea Thomson, Marie‐Claude Beauchamp, et al.. (2025). Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State. JAMA Health Forum. 6(8). e252329–e252329. 1 indexed citations
2.
Beauchamp, Marie‐Claude & Loydie A. Jerome‐Majewska. (2024). A protective role for EFTUD2 in the brain. Neuron. 112(20). 3378–3380. 3 indexed citations
3.
Bareke, Eric, et al.. (2023). Sf3b4 regulates chromatin remodeler splicing and Hox expression. Differentiation. 131. 59–73. 6 indexed citations
4.
Beauchamp, Marie‐Claude, Anissa Djedid, Eric Bareke, et al.. (2021). Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53. Human Molecular Genetics. 30(9). 739–757. 28 indexed citations
5.
Beauchamp, Marie‐Claude, et al.. (2019). Loss of function mutation of Eftud2, the gene responsible for mandibulofacial dysostosis with microcephaly (MFDM), leads to pre-implantation arrest in mouse. PLoS ONE. 14(7). e0219280–e0219280. 20 indexed citations
6.
Philip, Charles‐André, Ido Laskov, Marie‐Claude Beauchamp, et al.. (2017). Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors. BMC Cancer. 17(1). 638–638. 81 indexed citations
7.
Laskov, Ido, et al.. (2016). Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines. International Journal of Gynecological Cancer. 26(7). 1213–1221. 26 indexed citations
8.
Marques, Maud, Marie‐Claude Beauchamp, Hubert Fleury, et al.. (2015). Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors. BMC Medicine. 13(1). 217–217. 16 indexed citations
9.
Beauchamp, Marie‐Claude, et al.. (2015). Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors. BMC Cancer. 15(1). 817–817. 23 indexed citations
10.
Laskov, Ido, Laura M. Drudi, Marie‐Claude Beauchamp, et al.. (2014). Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer. Gynecologic Oncology. 134(3). 607–614. 84 indexed citations
11.
He, Gang, Christina Holcroft, Marie‐Claude Beauchamp, et al.. (2012). Combination of Serum Biomarkers to Differentiate Malignant From Benign Ovarian Tumours. Journal of Obstetrics and Gynaecology Canada. 34(6). 567–574. 12 indexed citations
12.
Yasmeen, Amber, et al.. (2011). Relevance of the OCT1 transporter to the antineoplastic effect of biguanides. Biochemical and Biophysical Research Communications. 414(4). 694–699. 70 indexed citations
13.
Beauchamp, Marie‐Claude, et al.. (2010). Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer. Journal of Oncology. 2010. 1–11. 57 indexed citations
14.
Beauchamp, Marie‐Claude, Amber Yasmeen, Joan M. Carboni, et al.. (2009). BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide. Gynecologic Oncology. 115(2). 193–198. 28 indexed citations
15.
Gotlieb, Walter H., Marie‐Claude Beauchamp, Jing Gu, et al.. (2008). In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecologic Oncology. 110(2). 246–250. 230 indexed citations
16.
Hihi, Abdelmadjid K., Marie‐Claude Beauchamp, Robyn Branicky, et al.. (2007). Evolutionary conservation of drug action on lipoprotein metabolism-related targets. Journal of Lipid Research. 49(1). 74–83. 7 indexed citations
17.
Beauchamp, Marie‐Claude, Sophie‐Élise Michaud, Ling Li, Maryam Sartippour, & Geneviève Renier. (2004). Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression. Journal of Lipid Research. 45(9). 1749–1757. 14 indexed citations
18.
Li, Ling, Marie‐Claude Beauchamp, & Geneviève Renier. (2002). Peroxisome proliferator-activated receptor α and γ agonists upregulate human macrophage lipoprotein lipase expression. Atherosclerosis. 165(1). 101–110. 38 indexed citations
19.
Beauchamp, Marie‐Claude, Elaine D. Letendre, & Geneviève Renier. (2002). Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia. Journal of Lipid Research. 43(2). 215–222. 43 indexed citations
20.
Zouki, Christine, Marie‐Claude Beauchamp, Chantal Baron, & János G. Filep. (1997). Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.. Journal of Clinical Investigation. 100(3). 522–529. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiya Sato Breakdown of academic impact, for papers by Luisa Salvatori Breakdown of academic impact, for papers by Marie‐José Blouin Breakdown of academic impact, for papers by Wenru Tang Breakdown of academic impact, for papers by Yumi Takiyama Breakdown of academic impact, for papers by Krzysztof Goryca Breakdown of academic impact, for papers by Ayce Yesilaltay Breakdown of academic impact, for papers by Hisataka Shikama Breakdown of academic impact, for papers by Jinghuan Lv Breakdown of academic impact, for papers by Ashwini L. Chand
Rankless by CCL
2026